Status:
RECRUITING
COVID-19 Survivorship Registry
Lead Sponsor:
NYU Langone Health
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, th...
Detailed Description
The objectives for this study include providing structural and function information about lung and heart using chest imaging, MRI, Echo, Spirometry, and blood markers in order to assess severity of ca...
Eligibility Criteria
Inclusion
- have tested positive for SARS-CoV-2 and discharged from the ICU or,
- have tested positive for SARS-CoV-2 and have been discharged from hospital or,
- have tested positive for SARS-CoV-2 but was NOT hospitalized
- ages 18 and over, and
- competent and willing to sign informed consent and comply to all aspects of the protocol
- CONTROL Inclusion Criteria
- No clinical history of COVID-19,
- No active clinical symptoms indicative of possible COVID-19,
- Ages 18 and over,
- competent and willing to sign informed consent and comply to all aspects of the protocol
Exclusion
- • Participants cannot sign consent
- Any individual who meets any of the following criteria will be excluded from participation to the MRI or x-ray portion of the study:
- Participants who are pregnant or currently trying to get pregnant
- Participants unable to comply with any portion of the protocol (i.e. removing metals prior to entering the MRI scan room) or who have contraindications to MRI scanning (i.e., non-MRI-conditional pacemakers/defibrillators, pregnancy, ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants)
- Persistent symptoms related to COVID-19 (in which case the patient may be re-screened later) As is done for all patients undergoing clinical MRI in our department, each patient will be screened for contraindications to MRI with a routine questionnaire prior to scanning.
- CONTROL Exclusion Criteria
- Patients with any of the following are excluded from as controls:
- Pace maker
- Poorly controlled diabetes
- Poorly controlled Restrictive lung disease
- Heart failure
- Parkinson's Disease
- Hypertension
- Any diagnosis or history of autonomic neuropathy
Key Trial Info
Start Date :
July 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04527315
Start Date
July 17 2020
End Date
December 1 2027
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016